Your session is about to expire
← Back to Search
Carvedilol for Atrial Fibrillation
Study Summary
This trial will compare the effectiveness of two drugs, carvedilol and metoprolol, in preventing a heart rhythm disorder called atrial fibrillation.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have heart failure that affects my daily activities.You live in a place that is far away from other people or services.You are not expected to live for more than 1 year.I am unable to understand and agree to the study's details on my own.I cannot take Beta blockers due to severe side effects or other medical reasons.Your heart must be in a normal rhythm when you join the study.My atrial fibrillation is caused by a condition that can be treated or reversed.Your heart is not pumping blood effectively, with a measurement of 35% or less.You have had more than two episodes of symptomatic atrial fibrillation that lasted for more than 15 minutes each time, as shown on an ECG test.I have ongoing atrial fibrillation.
- Group 1: Metoprolol
- Group 2: Carvedilol
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are elderly individuals, over 80 years of age, qualified to participate in this clinical trial?
"This research is open to individuals over the age of legal consent and younger than ninety years old."
How many participants have enrolled in this research endeavor?
"Unfortunately, this research project has ceased to enroll participants. It was first published on May 1st 2012 and last edited on the 26th of May 2022. If you are seeking other studies, there are currently 477 clinical trials aiming to recruit patients with atrial fibrillation, as well as 41 Carvedilol-focused medical investigations actively recruiting."
Which ailments is Carvedilol regularly prescribed to address?
"Carvedilol is primarily used to treat heart failure, but it can also show efficacy in treating conditions like myocardial infarction, chronic stable angina pectoris, and hypesthesia."
Are there any vacancies still available to participate in this research project?
"At the present moment, this particular medical study is not accepting patient applications. The trial was first announced on May 1st 2012 and last updated on May 26th 2022. If you are searching for alternative trials to participate in, there are 477 studies looking for atrial fibrillation patients and 41 trials seeking people trialing Carvedilol."
To whom is this clinical investigation open for enrollment?
"This medical trial is looking to enrol 300 people aged 18-90 with atrial fibrillation. In addition, participants must be in sinus rhythm when they begin the study."
Have any further investigations been performed utilizing Carvedilol?
"Currently, 41 ongoing clinical trials are exploring the efficacy of Carvedilol with 9 being in Phase 3. Multiple sites have been set up across the country, Orlando included, and over nine hundred eighty seven locations are running studies related to this medication."
Share this study with friends
Copy Link
Messenger